The frequency of de novo TP53 mutations in this patient sample is at least 7% and may be as high as 20%. Conclusions: The possibility that de novo germline TP53 mutations are relatively common has ...

Abstract: Mass spectrometry is a key technology for the identification of small molecules. However, traditional methods that rely on database comparisons have difficulty with newly discovered ...